Technical Analysis for FULC - Fulcrum Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.99 | -0.66% | -0.02 |
FULC closed down 0.66 percent on Wednesday, November 20, 2024, on 41 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Hammer Candlestick | Bullish | -0.66% | |
| Lizard Bullish | Bullish Day Trade Setup | -0.66% | |
| Lower Bollinger Band Walk | Weakness | -0.66% | |
| New 52 Week Low | Weakness | -0.66% |
| Alert | Time |
|---|---|
| Possible NR7 | about 18 hours ago |
| Up 1% | about 22 hours ago |
| Lizard Bullish Entry | about 22 hours ago |
| Hammer Candlestick Entry | about 22 hours ago |
| Rose Above Previous Day's High | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that are developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disorder that leads to significant physical impairments and disability; and FTX-HbF, a small molecule designed to upregulate fetal hemoglobin in patients with sickle cell disease and b-thalassemia. Fulcrum Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Disease Disability Disorders Dystrophy Muscular Dystrophy Progressive Hemoglobin Infancy Sickle Cell Disease Thalassemia Facioscapulohumeral Muscular Dystrophy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Disease Disability Disorders Dystrophy Muscular Dystrophy Progressive Hemoglobin Infancy Sickle Cell Disease Thalassemia Facioscapulohumeral Muscular Dystrophy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.7 |
| 52 Week Low | 2.86 |
| Average Volume | 1,930,766 |
| 200-Day Moving Average | 7.19 |
| 50-Day Moving Average | 3.41 |
| 20-Day Moving Average | 3.28 |
| 10-Day Moving Average | 3.32 |
| Average True Range | 0.24 |
| RSI (14) | 32.89 |
| ADX | 17.51 |
| +DI | 21.01 |
| -DI | 27.80 |
| Chandelier Exit (Long, 3 ATRs) | 3.23 |
| Chandelier Exit (Short, 3 ATRs) | 3.57 |
| Upper Bollinger Bands | 3.68 |
| Lower Bollinger Band | 2.89 |
| Percent B (%b) | 0.13 |
| BandWidth | 23.99 |
| MACD Line | -0.20 |
| MACD Signal Line | -0.20 |
| MACD Histogram | 0.0048 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.15 | ||||
| Resistance 3 (R3) | 3.15 | 3.11 | 3.12 | ||
| Resistance 2 (R2) | 3.11 | 3.07 | 3.10 | 3.11 | |
| Resistance 1 (R1) | 3.05 | 3.04 | 3.08 | 3.04 | 3.10 |
| Pivot Point | 3.00 | 3.00 | 3.02 | 3.00 | 3.00 |
| Support 1 (S1) | 2.94 | 2.96 | 2.97 | 2.94 | 2.88 |
| Support 2 (S2) | 2.90 | 2.94 | 2.89 | 2.87 | |
| Support 3 (S3) | 2.84 | 2.90 | 2.86 | ||
| Support 4 (S4) | 2.83 |
